Businesses can apply for a share of £3.7 million to develop processes that improve manufacturing of advanced drug therapies.
New drugs and therapies that meet the needs of individual patients have the potential to revolutionise healthcare in the UK. Manufacturing these new drugs and getting them to the patient at the right time is a significant challenge for UK businesses.
Please register or login to comment!
Register now Login